Immune to Cancer: The CRI Blog
-
A Promise Kept: Investing in the Scientists Shaping What Comes Next
There are moments when an organization’s mission is tested not by opportunity, but by uncertainty. This past… -
A Scientific Family Reunion: Immunology, Cancer, and the Power of Mentorship
The Rudensky Symposium on Immunity, Inflammation and Tolerance, held on August 27–28, 2026, was more than a… -
Does CAR T-Cell Cancer Therapy Affect Fertility? A New Study Is Looking for Answers
Contributing author: Blood Cancer United Some cancers and cancer treatments can affect fertility. Researchers are gathering better… -
Meet the 2026 STARs: Julie Deutsch, MD
The future — it’s no longer about whether a therapy worked in aggregate. It’s now about whether… -
Before Cancer Takes Hold: The Science of Cancer Interception
For the first time, CLIP applications will focus on a designated scientific theme: primary and secondary cancer prevention and interception…. -
It Takes a Village to Carry Cancer
Everybody thinks about the actual cancer patient. They don’t always think about the number of people who… -
A New Milestone for Cancer Vaccines — Decades in the Making
For decades, researchers have pursued an ambitious idea: What if a vaccine could teach a patient’s immune… -
Can Viruses Fight Cancer? What Tudriqev Means for Patients With Melanoma
The U.S. Food and Drug Administration’s (FDA) accelerated approval of Tudriqev marks FDA’s first new approval of… -
Meet the 2026 STARs: Aaron Whiteley, PhD
I’m a microbiologist who’s passionate about immune signaling. Meet Aaron Whiteley, PhD, an Assistant Professor in the…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.